Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

516.00

-15.00 (-2.82%)

At close: Oct 7, 2026

Market Cap	81.37B -2.3%
Revenue (ttm)	11.69M +482.1%
Net Income	-479.38M
EPS	-3.11
Shares Out	158.00M
PE Ratio	n/a
Forward PE	486.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	741,773
Open	532.00
Previous Close	531.00
Day's Range	515.00 - 537.00
52-Week Range	300.00 - 747.00
Beta	n/a
Analysts	Strong Buy
Price Target	841.25 (+63.03%)
Est. Earnings	Oct 16, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $841.25, which is an increase of 63.03% from the latest price.

Price Target

$841.25

(63.03% upside)

Analyst Consensus: Strong Buy

Stock Forecasts